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Summary.-Following injection into the portal venous or vena caval systems,
tumour cells are held up almost exclusively in the liver or lung respectively, and
subsequent outgrowth of tumour only occurs in these organs.
Following systemic arterial injection, cells are distributed, and subsequently
grow, in a variety of organs. However, the adrenal gland supports tumour growth
from much fewer cells than the lung, and this is partly due to the fact the rate of
tumour cell loss in the initial 48 h is very high in the latter compared to the former
organ.
THE factors determining the patterns
of metastatic spread are complex and at
present poorly understood. Two long-
standing theories, " the soil seed hypo-
thesis " of Paget (1889) and the " mecha-
nical theory " of Ewing (1928) aroused
considerable controversy for several de-
cades and have been summarized by
Willis (1952). Paget considered that the
microenvironment of one organ might
favour the seeding and growth of blood-
borne tumour cells over another organ,
while Ewing stated that " the mechanics
of the circulation will doubtless explain
most of these peculiarities; for there is no
one parenchymatous organ more adapted
than others to the growth of embolic
tumour cells ".
While published data have supported
either Ewing's (Coman, Delong and Mc-
Cutcheon, 1951; Coman, 1953) or Paget's
(Sugarbaker, 1952; Kinsey, 1960) theories,
we are not aware of a previous report
which supports both theories with data
from a single animal tumour model. The
present study demonstrates a predominant
influence of " mechanical " factors on the
site of outgrowth of bloodborne tumour
cells following injection into the vena
caval or portal circulation and yet, on
injection into the aorta, the outgrowth of
the same tumour cells appears to be
governed by other considerations, most
probably involving variations in the local
environment of different organs.
MATERIAL AND METHODS
Single-cell suspensions were prepared by
enzymatic digestion from the 6-12th transfer
generations of the MCI sarcoma, maintained
in the inbred Chester Beatty hooded rat
strain of origin. Viable portions of tumour
w,ere incubated in 25 ml MEM (Microbio-
logical Associates, U.S.A.) containing 0-13 g
of trypsin, 0-15g of collagenase and trace
amounts of DNAase (all Sigma Type I),
filtered through gauzeandwashedthoroughly.
Radioactive label was incorporated by in-
cubating 106 single tumour cells in Falcon
flasks containing 25 ml of MEM with 10%
foetal calf serum (Microbiological Associates)
and 5 ,uCi 125IUdR (N.E.N., Canada) for 48 h.
The cells were then harvested by incubation
for 10 min with 022% trypsin, and repeated
washing to remove excess label. Such cells
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have a labelling index of > 97% on auto-
radiographic studies (personal observations)
and following i.v. injection, produce a similar
amount oflung tumour to the injection of an
identical number of unlabelled tumour cells
(Proctor et at., 1976). Volumes of 1 ml,
containing between 2 x 105 and 106 labelled
or unlabelled single-cell suspensions, were
injected intravascularly and the extent of
tumour growth assessed by weighing in-
filtrated organs 3-4 weeks later. The initial
distribution of tumour cells was assessed by
counting radioactivity in organs on a con-
ventional gamma counter 10 min after injec-
tion, and the loss of radiolabel from these
organs was monitored by killing rats at
various times thereafter.
RESULTS AND DISCUSSION
In an initial experiment, 2 x 105 MCI
sarcoma cells, containing approximately
2 x 104 ct/min, were injected via the
lateral tail vein, or following laparotomy
under ether anaesthesia, via the superior
mesenteric vein, and the distribution of
the radioactivity and the subsequent
outgrowth of tumour recorded. Tail vein
injections led to an almost complete
retention of cells and subsequent tumour
growth in the lung, while following
injection into the superior mesenteric
vein, tumour cells were almost completely
retained in the liver, and grew subse-
quently only in that organ (see Table I).
However, following injection of un-
labelled tumour cells into the abdominal
aorta, below the coeliac axis, macroscopic
tumour was identified subsequently in a
variety oforgans and tissues (see Table II).
In subsequent experiments the distri-
bution of radiolabelled tumour cells per
organ was established 10 miit after aortic
injection of 2 X 105 radiolabelled tumour
TABLE II.-Distribution of Macroscopic
Tumour Nodules after Intra-arterial In-
jection of MCI Tumour Cells
Incidence of tissue or organ involvement in
5 animals following injection with
106 cells 2 x 105 cells
Lungs 5 5
Prostate 5 4
Bone 5 5
Skeletal muscle 5 5
Subcutaneous and
peritoneal soft tissues
Adrenals
Lymph nodes
Seminal vesicles
Liver
Kidney
Bladder
5
5
5
3
2
1
1
5
4
2
1
0
0
0
No tumour was detected in spleen, pancreas,
intestines, testes, brain, thyroid, thymus, heart or
eyes.
Single-cell suspensions were prepared (see Table
I) and 106 or 2 x 105 tumour cells in 1 ml injected
into the aorta above the renal arteries via a 27-gauge
needle through a midline abdominal incision,under
ether anaesthesia.
The animals were killed 3-4 weeks later, and
organs and tissues examined formacroscopic tumour.
TABLE I.-% of Injected Cells in Lung and Liver, 10 mmn after i.v. Injection, and their
Subsequent Outgrowth
Site of injection
Tail vein
Experiment 1
Experiment 2
Superior mesenteric vein
Experiment 1
Experiment 2
Number of
animals/group
5
5
5
5
Incidence of
% (and range) of injected cells in tumour growth in
Lung Liver Lung L
Lung Liver Lung Liver
86-2
(82-4-93- 1)
82-3
(77-4-92-4)
0
0
1*5
(12 2-2 3)
1*2
(10-1-8)
96-6
(91.2-104-5) 94.7
(90 9-96 3)
5/5 0/5
5/5 0/5
0/5 5/5
0/5 5/5
Some rats were exsanguinated and organs removed 10 min after injection, and the radioactivity within
them counted on a conventional gamma counter (counts > 3 x background were considered significant).
Others were killed 3-4 weeks after injection, and examined for macroscopic tumours in all organs and tissues.
No tumour was identified in tissues or organs other than the lung and liver.
652FATE OF BLOODBORNE RAT SARCOMA CELLS
TABLE III.-Distribution Patterns of MC1 Tumour Cells and Subsequent Growth after
Injection into the Abdominal Aorta
Organ
Experiment 1
Lung
Adrenals
Prostate and appendages
Large intestine
Experiment 2
Lung
Adrenal
Prostate and appendages
Large intestine
Mean number of cells
10 min after injection
Per gram
Per organ of organ
168181
372
5662
10378
111290
137
5155
8129
86663
3437
9760
8392
68012
1245
9372
7069
Incidence of
tumour
growth
6/6
6/6
6/6
0/6
5/5
5/5
5/5
0/5
Approximate mean weight
of tumour (g) 21-28 days
after injection
Per gram
Per organ of organ
2-18
1-75
2-85
0
3-14
1 -96
2-21
0
1 09
17-50
4-31
0
1-89
17-8
3-81
0
Single-cell suspensions of tumour were prepared and labelled with 125IUDR and injected into the
abdominal aorta. Some animals were exsanguinated 10 min later and the organs weighed and counted for
radioactivity. The number oftumourcellsperorganwascalculated asfollows:
Number of tumour cells/organ = ct/min/organ x Total number of tumour cells injected Total ct/min injected
Other rats were killed 3-4 weeks later and the organs and tissues examined for tumour. The tumour
in the lung, adrenal glands and prostate was weighed to the nearest 0- 1 g, as follows:
Approximate tumour wt/g of organ - Weight of organ with tumour - Weight of tumour-free organ Weight of tumour-free organ
cells containing approximately 2 x 104
ct/min, and the approximate amount of
tumour resulting in each organ from these
cells was determined by weighing in-
filtrated organs 3 weeks later.
Radiolabelled tumour cells dispersed
widely following aortic injection (see
Table III), but the proportion of cells in
the adrenal glands was extremely low,
considering the high incidence of tumour
growth observed in these organs following
injection with unlabelled cells (see Table
II). Furthermore, each gram of tumour
in the lung resulted from a much higher
number of tumour cells than did each
gram of tumour in the prostate, and more
particularly in the adrenal gland (see
Table III).
These findings support the hypothesis
of Paget, and might simply imply different
rates of tumour growth in these organs.
However, previous experiments (Proctor
et al., 1976), like those of Fidler (1970),
have shown that, following retention of
circulating tumour cells in the lung, the
cells are rapidly destroyed there, in
contrast to a much lower rate of cell loss
from subcutaneousorintramusculartissues
(Peters and Hewitt, 1974). Therefore a
further experiment was set up, to follow
the initial fate of radiolabelled tumour
cells inthe above organsfollowinginjection
into the aorta. The rate of tumour cell
loss during the first 46 h after injection
(see Fig.) in the adrenal gland, and to a
lesser extent in the prostate gland, was
very much slower than in the lung.
These findings explain partially the
large amount of tumour resulting from a
few tumour cells in the adrenal glands,
compared to the similar amount of
tumour resulting from a very large
number of cells in the lung. They do not
explain why no tumour grew in the large
intestine, as there were still 2-3 times the
number of cells in this organ compared to
the number in the adrenal at 46 h.
However, when expressed as a concentra-
tion of tumour cells/g of organ, the con-
centration in the adrenal is 20-30 times
greater than in the small intestine, and
this might explain the discrepancy in the
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x oF TUMOUR CELLS
REMAINING AFTER 46 HOURS
LuNG 4 4
LARGE INTESTINE 8-7
105 PROSTATE 15-4
ADSRENALS 66 3
C, 104 i 4
lu'K ~ ~ ~ '
103 PQTu
LARGE INTESTINE
0 2l0 20 30 40
HOURS AFTER AORTIC INJECTION
FIG.-Rateofdestruction of125IUDR-labelled
MCI tumour cells in various organs follow-
ing aortic injection.
Radiolabelledtumnourcellswereinjected into
the aorta, 5 rats exsanguinated at 10 min,
1, 6, 10, 18 and 46 h after injection, and the
radioactivity within the lung, adrenals,
prostate and small intestine counted.
outgrowth of tumour in these two
organs.
Nevertheless, this does not explain why
a similar amount of tumour results in the
lungs and in the adrenals, as on a weight-
for-weight basis the number of tumour
cells/g of lung is still considerably higher
than the number of cells/g of adrenal
gland at 46 h. Thus the differences
observed in the rate of tumour cell loss
from various organs is not a complete
explanation, although it is undoubtedly
an important feature.
The results support both the " mecha-
nical theory " ofEwing and the " soil seed
hypothesis " of Paget, and in this respect
are analogous to observations in human
cancer. Thus, abdominal tumours drained
by the portal venous system spread to
liver, and tumours of the peripheries such
as sarcomata spread primarily to the lung.
However, very large adrenal metastases
occur in the presence of small secondary
deposits in other organs, from small
primary bronchogenic carcinomas, which
is consistent with Paget's hypothesis.
In summary, it is probable that, while
the relative importance of " mechanical "
and " soil " factors will vary from one
form of cancer to another, " mechanical "
factors may influence the pattern of
secondary venous spread predominantly
to the lung, while tertiary spread through
the arterial circulation from such meta-
stases may be determined to a much
greater extent by "soil" factors.
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